1250 MG/SQ. METER ADMINISTERED ORALLY TWICE DAILY (MORNING AND EVENING; EQUIVALENT TO 2500 MG/SQ. M. TOTAL DAILY DOSE) FOR 2 WEEKS FOLLOWED BY A 1-WEEK REST PERIOD GIVEN AS 3-WEEK CYCLES. IT SHOULD BE SWALLOWED WITH WATER WITHIN 30 MINUTES AFTER A MEAL.
IN COMBINATION WITH DOCETAXEL, THE RECOMMENDED DOSE OF CAPECITABINE IS 1250 MG/SQ. M. TWICE DAILY FOR 2 WEEKS FOLLOWED BY A 1-WEEK REST PERIOD, COMBINED WITH DOCETAXEL AT 75 MG/SQ. M. AS A 1-HOUR INTRAVENOUS INFUSION EVERY 3 WEEKS. PRE-MEDICATION, ACCORDING TO THE DOCETAXEL LABELING, SHOULD BE STARTED PRIOR TO DOCETAXEL ADMINISTRATION FOR PATIENTS RECEIVING THE CAPECITABINE PLUS DOCETAXEL COMBINATION.
DOSE
STAGE III COLON CANCER, ADULT OVER 18 YEARS 1.25 G/SQ. M. TWICE DAILY FOR 14 DAYS, FOLLOWED BY A 7-DAY INTERVAL, GIVEN AS 3-WEEK CYCLES FOR A TOTAL OF 8 CYCLES
METASTATIC COLORECTAL CANCER, ADULT OVER 18 YEARS 1.25 G/SQ. M. TWICE DAILY FOR 14 DAYS; SUBSEQUENT COURSES REPEATED AFTER A 7-DAY INTERVAL
ADVANCED GASTRIC CANCER, ADULT OVER 18 YEARS 1 G/SQ. M. TWICE DAILY FOR 14 DAYS; SUBSEQUENT COURSES REPEATED AFTER A 7-DAY INTERVAL
NOTE THE FIRST DOSE SHOULD BE TAKEN ON THE EVENING OF DAY 1 AND LAST DOSE ON THE MORNING OF DAY 15; DOSE DIFFERS IN COMBINATION WITH EPIRUBICIN - CONSULT PRODUCT LITERATURE
BREAST CANCER, ADULT OVER 18 YEARS 1.25G/SQ. M. TWICE DAILY FOR 14 DAYS; SUBSEQUENT COURSES REPEATED AFTER A 7-DAY INTERVAL